136
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Hypertrophic pachymeningitis and subdural haematoma in an otitis media with ANCA-associated vasculitis patient successfully treated with intravenous cyclophosphamide

, , , , , , & show all
Pages 134-138 | Received 22 Aug 2018, Accepted 28 Feb 2019, Published online: 05 Apr 2019

References

  • Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.
  • Harabuchi Y, Kishibe K, Tateyama K, et al. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan. Mod Rheumatol. 2017;27:87–94.
  • Yoshida N, Iino Y. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis. Allergol Int. 2014;63:523–532.
  • Yonekawa T, Murai H, Utsuki S, et al. A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry. 2013;85:737–739.
  • Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2006;66:222–227.
  • Kobari Y, Nagasawa T. Otitis media with ANCA-associated vasculitis: a new concept and the associated criteria. Intern Med. 2017;56:3365–3367.
  • Yokoseki A, Saji E, Arakawa M, et al. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain. 2014;137:520–536.
  • Lim E-J, Kim SH, Lee SH, et al. Reversible sensorineural hearing loss due to pachymeningitis associated with elevated serum MPO-ANCA. Clin Exp Otorhinolaryngol. 2011;4:155–158.
  • Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583–1594.
  • Okada M, Hato N, Okada Y, et al. A case of hypertrophic cranial pachymeningitis associated with invasive Aspergillus mastoiditis. Auris Nasus Larynx. 2015;42:488–491.
  • Yokote H, Terada T, Nakai K, et al. Subdural and meaningful involvement related to Wegener's granulomatosis: case report. Neurosurgery. 1997;40:1071–1073.
  • Shiotani A, Mukobayashi C, Oohata H, et al. Wegener’s granulomatosis with dural involvement as the initial clinical manifestation. Intern Med. 1997;36:514–518.
  • Kalra S, Yadav A, Agarwal S, et al. Wegener's granulomatosis with subdural hematoma as the initial manifestation. Int J Crit Illn Inj Sci. 2013;3:88–90.
  • Okada M, Suemori K, Takagi D, et al. The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis. Auris Nasus Larynx. 2019;46:38–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.